4,272 reports of this reaction
3.9% of all METFORMIN HYDROCHLORIDE reports
#1 most reported adverse reaction
LACTIC ACIDOSIS is the #1 most commonly reported adverse reaction for METFORMIN HYDROCHLORIDE, manufactured by Santarus, Inc.. There are 4,272 FDA adverse event reports linking METFORMIN HYDROCHLORIDE to LACTIC ACIDOSIS. This represents approximately 3.9% of all 110,881 adverse event reports for this drug.
Patients taking METFORMIN HYDROCHLORIDE who experience lactic acidosis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LACTIC ACIDOSIS is moderately reported among METFORMIN HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to lactic acidosis, the following adverse reactions have been reported for METFORMIN HYDROCHLORIDE:
The following drugs have also been linked to lactic acidosis in FDA adverse event reports:
LACTIC ACIDOSIS has been reported as an adverse event in 4,272 FDA reports for METFORMIN HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
LACTIC ACIDOSIS accounts for approximately 3.9% of all adverse event reports for METFORMIN HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience lactic acidosis while taking METFORMIN HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.